338 related articles for article (PubMed ID: 28882609)
1. Atypical meningioma. A study on recurrence and disease-specific survival.
Champeaux C; Houston D; Dunn L
Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
[TBL] [Abstract][Full Text] [Related]
2. WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.
Champeaux C; Wilson E; Shieff C; Khan AA; Thorne L
J Neurooncol; 2016 Sep; 129(2):337-45. PubMed ID: 27311726
[TBL] [Abstract][Full Text] [Related]
3. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
Champeaux C; Dunn L
World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
[TBL] [Abstract][Full Text] [Related]
4. World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Champeaux C; Jecko V
Neurochirurgie; 2016 Aug; 62(4):203-8. PubMed ID: 27339832
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
6. World Health Organization grade II meningiomas.
Champeaux C; Dunn L
Acta Neurochir (Wien); 2016 May; 158(5):921-9; discussion 929. PubMed ID: 27020441
[TBL] [Abstract][Full Text] [Related]
7. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
[TBL] [Abstract][Full Text] [Related]
8. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
9. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
[TBL] [Abstract][Full Text] [Related]
10. WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
Gallagher MJ; Jenkinson MD; Brodbelt AR; Mills SJ; Chavredakis E
Clin Neurol Neurosurg; 2016 Feb; 141():117-21. PubMed ID: 26780494
[TBL] [Abstract][Full Text] [Related]
11. Malignant Meningioma: An International Multicentre Retrospective Study.
Champeaux C; Jecko V; Houston D; Thorne L; Dunn L; Fersht N; Khan AA; Resche-Rigon M
Neurosurgery; 2019 Sep; 85(3):E461-E469. PubMed ID: 30566646
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
13. Clear cell histology portends a worse prognosis than other WHO grade II histologies.
Soni P; Shao J; Momin A; Lopez D; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
J Neurooncol; 2021 Jan; 151(2):307-312. PubMed ID: 33398533
[TBL] [Abstract][Full Text] [Related]
14. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
[TBL] [Abstract][Full Text] [Related]
15. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
Gousias K; Schramm J; Simon M
J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
[TBL] [Abstract][Full Text] [Related]
16. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
17. Simpson grade: an opportunity to reassess the need for complete resection of meningiomas.
Heald JB; Carroll TA; Mair RJ
Acta Neurochir (Wien); 2014 Feb; 156(2):383-8. PubMed ID: 24193889
[TBL] [Abstract][Full Text] [Related]
18. High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
Bender L; Somme F; Lhermitte B; Ahle G; Boone M; Blonski M; Pouget C; Truc G; Cebula H; Noël G
Chin Clin Oncol; 2021 Jun; 10(3):26. PubMed ID: 33752411
[TBL] [Abstract][Full Text] [Related]
19. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
[TBL] [Abstract][Full Text] [Related]
20. Meningeal haemangiopericytoma and solitary fibrous tumour: a retrospective bi centre study for outcome and prognostic factor assessment.
Champeaux C; Khan AA; Wilson E; Thorne L; Dunn L
J Neurooncol; 2017 Sep; 134(2):387-395. PubMed ID: 28691143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]